Phase 4, Interventional, Multicenter, Open-Label, Single-Arm Study
Project Description:
A Phase 4, Interventional, Multicenter, Open-Label, Single-Arm Study to Assess Behavioral and Other Co-occurring Outcomes Following Treatment With EPID(I/Y)OLEX as Add-on Therapy in Participants (Aged 1 to 65 Years Old) With Seizures Associated With Tuberous Sclerosis Complex (EpiCom)
Role: Principal Investigator: Dr. Sarah Wilson.
8/2023 – Present.
Core Function(s):
Performing Direct and/or Demonstration Services, Continuing Education/Community Training, Demonstration Services
Area of Emphasis
Education & Early Intervention
Target Audience:
Adults with Disabilities
Unserved or Under-served Populations:
Other
Primary Target Audience Geographic Descriptor:
National
COVID-19 Related Data:
N/A